Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine
Tarih
2012Üst veri
Tüm öğe kaydını gösterÖzet
The purpose of the present study was to overcome resistance to imatinib (IM) by combining it with roscovitine (ROSC) and to investigate whether or not midkine (MK) had an effect on this combination in the treatment of glioblastoma (GBL). Human T98 GBL cel
Bağlantı
https://doi.org/10.3892/ol.2011.434http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2313
Koleksiyonlar
DSpace@İYYU by Istanbul Yeni Yüzyil University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..
